malondialdehyde has been researched along with Motor Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SS; Gazzaz, ZJ; Ibraheem, MS; Murad, HA | 1 |
| Abnous, K; Hosseinzadeh, H; Mohammadzadeh, L; Razavi, BM | 1 |
2 other study(ies) available for malondialdehyde and Motor Disorders
| Article | Year |
|---|---|
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.
Topics: Alanine Transaminase; Ammonia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; End Stage Liver Disease; Enzyme-Linked Immunosorbent Assay; gamma-Glutamyltransferase; Glutathione; Liver; Liver Cirrhosis; Locomotion; Losartan; Male; Malondialdehyde; Motor Disorders; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Thioacetamide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats.
Topics: Acetylcholinesterase; Animals; Carotenoids; Crocus; Glutathione; Insecticides; Lipid Peroxidation; Malathion; Male; Malondialdehyde; Motor Disorders; Neuroprotection; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Wistar | 2018 |